Decision Resources, which is considered to be one of the world’s top research and advisory firms for pharmaceutical and healthcare related matters revealed that while compared to other agents presently available, Centocor Ortho Biotech/Merck/Mitsubishi Tanabe Pharma’s Remicade (infliximab) has been chosen as the most effectual therapy for the treatment of minor to severe ulcerative colitis by the […]
